Immunogenicity and efficacy of DNA/MVA HIV vaccines in rhesus macaque models
Introduction: Despite 30 years of research on HIV, a vaccine to prevent infection and limit disease progression remains elusive. The RV144 trial showed moderate, but significant protection in humans and highlighted the contribution of antibody responses directed against HIV envelope as an important...
Saved in:
Main Authors: | Lynette Siv Chea (Author), Rama Rao Amara (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2017-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Poxviral promoters for improving the immunogenicity of MVA delivered vaccines
by: Naif Khalaf Alharbi
Published: (2019) -
Characterization of HIV-1 Nucleoside-Modified mRNA Vaccines in Rabbits and Rhesus Macaques
by: Norbert Pardi, et al.
Published: (2019) -
Assisted reproductive technologies in rhesus macaques
by: Wolf Don P
Published: (2004) -
Immunogenicity of a protective intradermal DNA vaccine against lassa virus in cynomolgus macaques
by: Jingjing Jiang, et al.
Published: (2019) -
Immunogenicity and safety of an Entamoeba histolytica adjuvanted protein vaccine candidate (LecA+GLA-3M-052 liposomes) in rhesus macaques
by: Mayuresh M. Abhyankar, et al.
Published: (2024)